Yesterday, I again discussed with a friend about the future of the pharmaceutical industry and its future business models. We asked ourselves critically:
How will pharma business grow sustainable in future or decline in its core business? Which position or role will it take in todays&future Healthcare Society? What could other addiotinal subcore businesses can be? Sometimes we need to ask ourselves the right questions before finding a solution:
We can say that in many health and profit promising diseases, more accurately common diseases like in MT,CNS and Pain relief… has been researched, basically enough and there is no real market anymore…., which stil could be interesting for pharma? Or solving diseases for humanity? So whats about inventing more diseases? More diseases, more products, more profit? Pfizer has tried it with FDS (Female dysfunction or better said Viagra for women) or other multis who launch “Mee-too’s” as high innovative solutions…for…? yes for what? For existing indications. As we could also use Generic products?
A long chain of industries and business are addicted to pharmaceutical business today, which is, on the first view not really conscious. In addition I can mention that numerous services do exist needs pharma! Where is the money…?
Market research companys, CRO (Contract Research Organizations such as drug delivery companies), marketing agencies, contract manufacturers, e-health organizations, or the whole infrastructure of hospitals & insurances.
I guess it is complex enough, to explain all the “players” in a healthcare system in context of future pharma business including their relationships in between. Now it should be clear, although we may see the dark side of healthcare in pharma, many players bound and need them. So lets speculate, new research projects in genomics and gene-technology, personalized medicines, anti-bodys instead of new chemical entities, with companies and products like in process innovation “Thinking design” and IDEO…success?..No its not promising but may showing a new direction helping to innovate? But innovation means not entrepreneurship…!
Many factors and no solution? A major trend I observed in many cases are the optimization and maximum usage of existing technologys. E.g. eveluating further succes of existing products with improvement, an example: Gx to SuperGx, which may show potential in markets like US. I think it must be invested in drugs and research projects, why not investing in some dreams humanity had over decades: Increasing human intelligence, human memory, brain power, immunity, beauty, power, against aging and resistance…!
Is this maybe the way pharma should go? Or stay on core routes like researching for Onco, CNS… in a healthcare service environment and not lifestyle ..?
Although the government managed to reduce by 21% the use of antibiotic drugs in France between 1999 and 2004, this consumption does not change over the past five years (Afssaps).
English
Français